Sign inJoin waitlistJoin the waitlist

Eveline Stock

Associate Professor · University of California (San Francisco) School of Medicine

Credentials: · · ·

History

University of California-San Francisco
2012–2013
University of California-San Francisco
2011–2012
Cardiovascular Disease
University of California-San Francisco
2007–2010
Internal Medicine
Massachusetts General Hospital
2004–2007
Pontificia Universidad Católica de Chile Escuela de Medicina
1990–1994

Research

Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology
The Journal of Clinical Endocrinology & Metabolism · 2000 · 359 citations
Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus
Endocrinology · 2006 · 154 citations
Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study
Brain Research · 1994 · First of 6 authors · 122 citations

John Kane
18 papers
MM
Mary Malloy
16 papers
GA
Gail Adler
5 papers
DM
Diego Martinez-Vasquez
3 papers
ES
Ernst Schaefer
3 papers
GW
Gordon Williams
3 papers
VR
Vincent Ricchiuti
3 papers
Alexander Quinn
2 papers · 1 as a fellow
ES
Ellen Seely
2 papers
Gregory Enns
2 papers
James Januzzi
2 papers
James Stone
2 papers · 1 as a fellow

Clinical trials

Impact of Physical Activity on Left Ventricular Mass and Lipid Metabolism
Principal investigator · Terminated
University of California, San Francisco
2011–2017
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2026–2030
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
2024–2030